It must be rough for asap to literally be the smartest person in every conversation he's ever had. Must be a terrible burden to bear

Care to elaborate and add some value to this thread what I said you disagree with? I'm fine admitting when I'm wrong, plenty of people smarter than me. Like to voice my opinion like everyone else on here.

https://business.financialpost.com/c...ot-stock-slide

Machines taking advantage of panic sellers and sls caused by modest profit taking. Tgod diluted down <$3, aurora <$8, canopy <$40, buy buy buy all you can eat baby

almost forgot Ianthus and Khiron...

I don't see any bulls in here panicking.

10 billion is considered a low estimate by some. Plus everyone knows it's about these companies expanding outside of Canada.

I was selling CGC in the 50s, but they are still positioned to be the leader and expand globally. Under 40 their market cap is ~8.5B.

Only holding a couple Canadian that I think are undervalued relative to CGC (Aphria primarily).

Isnt Aurora the only one with a +ve P/E? Rumors of coke deals and they're the only supplier in a couple provinces so I'd think that one would be one of the ones to go long on, but I dont know much about it. I made 5 figures on the volatility of EMH a year or so ago and sold at the top.

As for Canadian expansion into the US market particularly, ain't gonna happen anytime soon

Got some more Khiron when it dropped down. I still think it has potential to be huge long term. That could be years away though. Holding ACB for the long as well. Who knows it could drop more idk. I'd like to hold it for at least a year and see how 2019 plays out.

Some thoughts.

I don't like the index funds. High charges at .75%, and there are so few stocks composing them, you can just read off their holdings and invest direct. Or are people buying them just for the gamble?

CBD is a gimmick, beyond some narrow legit medical uses like for epilepsy. So NBEV or David's tea have little edge over other new age fakery drinks. Unless they start adding THC.

Weed can be produced incredibly cheaply, it's already a commodity. The money will be in value-added products like oils, shatter, THC drinks, and distribution thereof. This makes HYYDF tantalizing because it partnered with Coors-Molson for a THC drink.

In one year, Canada legalizes the eating and drinking products. That should create some stir.

Eons ago I traded on a lot of internet gambling stocks. The vast majority of the companies vanished. So I'm skeptical of US companies; they don't have a stable market, we're a ways from knowing who will survive. I prefer Canadian.

Is this based on empirical evidence or lack thereof?

At least here in OKC, they are popping up everywhere similar to vape shops when vaping was a fad. It's been advertised to old people on sports radio constantly. The only people I know who use it are pot heads who desperately want it to be a thing.

Ive never tried it, nor done any research, but I can see why it would come across as a gimmick. The market is definitely super oversaturated

The research on edibles is going to go on forever but I think it's safe to say the topical products are probably up there with magnetic bracelets and alkaline water.

This all seems completely unrelated to its efficacy.

You're right. I'm just saying it comes across as gimmicky the way it's being marketed

I tried some several times. Could detect no effect of any nature. Was not looking for a high, was interested in affect on mood, concentration, etc.

Checked out website of New Age Beverages. Sheer idiocy. So they have a CBD advertising hook that will bring in a few people who will convince themselves it works just like their essential oils used to. But random drinkers are not going to say "hey, this helps with my _____. I'll drink it everyday forever."

If a group besides epileptics gets something real from CBD I'll reconsider.

When taking proper CBD you feel a strong sensation of relaxation. It is also really good for sleep. When I take it I get extremely deep sleep.

CBD is cannibidiol, which is a cannabinoid just like THC, but without any psychoactive properties. There are many different types of cannabinoids that interact with our endocannabinoid system in a multitude of ways. How and to what effect is what is being studied.

CBD is not a gimmick. Lot of people take to help control inflammation and help sleep.

To me, "help control" inflammation means "nothing measurable so we'll just say it helps," which is the same as essential oils.

Interested to hear personal experiences of better sleep. Would like to see blind studies of the effect. Same with "relaxation," of which I felt nothing.

I'm sure you will be able to read through many clinical studies/trials in the future.

https://www.bloomberg.com/news/artic...grown-cannabis

"The technology’s application to the cannabis industry is clear, said Gorenstein. For example, a compound called tetrahydrocannabivarin, or THCV, acts as an appetite suppressant, potentially offsetting the “munchies” effect of pot. It appears in very small quantities in the cannabis plant, making it difficult and expensive to produce at scale. Using Ginkgo’s technology, pure THCV can be produced in a lab."

“Being able to consistently and efficiently produce high-purity cannabinoids, that’s the holy grail,” Gorsenstein said."

Mike Gorenstein is CEO of Cronos and is intelligent imo. Cronos is one of the LPs that hasn't directed all their resources to grow capacity, but are attempting to secure bioceutical(?) IP.


https://www.newswire.ca/news-release...693130791.html

https://canopy-health.ca/

"One of his companies, Canopy Health, filed 27 patents in the final months of 2017. Among the conditions the company hopes to conquer are insomnia, nervous system disorders and pain management. The company is even looking into veterinary products for pets.

Linton pegs the value of the world medical marijuana market at around $180 billion."

I'm not one to say its completely viable, but I smoke dope and have tried both highly concentrated THC and CBD strains and there are definitely noticeable effects that I think could be isolated.

Hemp will also play a role in all of this.

a lot of people take alpha brain too cuz it helps them with XXXXXX

The real winners will be biotechs that find medical use for cannabinoids not these commodity farmers that already have capturing the entire market and more priced in.

Inflammation is measurable.

There have been studies.

Thousands of Anecdotes.

It's like you didn't even google it.

CGC stock price has tripled+ in the past year. Is that not a "real winner"?

Lot of sour grapes in this thread.

Ima pass on doing the research to support your claim.

The cbd patent expires April 2019, and numerous pumps will occur leading up to and shortly after that. GWPH has a nice headstart, kannalife is another name but not trading yet. I'd expect more bio plays late next year, but whenever there is federal regulation its obviously a different ball game all together. Growth industry in every sense.

acktually, you'd be doing research your claim "CBD is a gimmick", which occurred first.